Andilum, Baby Girl .

HRN: 21-99-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2022
10/04/2022
IV
90mg
Q12
Neonatal Sepsis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: